Vimarsana
Biggest News Aggregation in the World

Page 19 - 45337c10 News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from 45337c10. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In 45337c10 Today - Breaking & Trending Today

Arizona State Retirement System Grows Position in Incyte Co. (NASDAQ:INCY) - Vimarsana News

Arizona State Retirement System Grows Position in Incyte Co. (NASDAQ:INCY)

Arizona State Retirement System raised its position in Incyte Co. (NASDAQ:INCY – Get Rating) by 3.5% during the fourth quarter, HoldingsChannel.com reports. The firm owned 53,516 shares of the biopharmaceutical company’s stock after buying an additional 1,821 shares during the quarter. Arizona State Retirement System’s holdings in Incyte were worth $4,298,000 at the end of […]

Incyte (NASDAQ:INCY) Lowered to "Buy" at StockNews.com - Vimarsana News

Incyte (NASDAQ:INCY) Lowered to "Buy" at StockNews.com

StockNews.com cut shares of Incyte (NASDAQ:INCY – Get Rating) from a strong-buy rating to a buy rating in a research report report published on Wednesday. Several other equities analysts have also issued reports on the company. Cowen raised their price target on Incyte from $95.00 to $100.00 and gave the stock an outperform rating in […]

Source: wkrb13.com
Incyte (NASDAQ:INCY) Price Target Cut to $73.00 by Analysts at Stifel Nicolaus - Vimarsana News

Incyte (NASDAQ:INCY) Price Target Cut to $73.00 by Analysts at Stifel Nicolaus

Incyte (NASDAQ:INCY – Get Rating) had its price objective decreased by Stifel Nicolaus from $80.00 to $73.00 in a report released on Wednesday, The Fly reports. Other research analysts also recently issued research reports about the stock. Cowen lifted their price objective on shares of Incyte from $95.00 to $100.00 and gave the company an […]

Source: wkrb13.com
Incyte (NASDAQ:INCY) Cut to Neutral at Bank of America - Vimarsana News

Incyte (NASDAQ:INCY) Cut to Neutral at Bank of America

Bank of America cut shares of Incyte (NASDAQ:INCY – Get Rating) from a buy rating to a neutral rating in a research note released on Thursday morning, The Fly reports. They currently have $84.00 price objective on the biopharmaceutical company’s stock. Other equities research analysts have also issued research reports about the company. Stifel Nicolaus […]

Incyte Co. (NASDAQ:INCY) Shares Sold by California Public Employees Retirement System - Vimarsana News

Incyte Co. (NASDAQ:INCY) Shares Sold by California Public Employees Retirement System

California Public Employees Retirement System reduced its stake in shares of Incyte Co. (NASDAQ:INCY – Get Rating) by 6.1% in the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 1,235,001 shares of the biopharmaceutical company’s stock after selling 79,795 shares […]